Avidity Partners Management LP Reduces Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Avidity Partners Management LP cut its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 38.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 489,119 shares of the specialty pharmaceutical company’s stock after selling 308,381 shares during the quarter. Jazz Pharmaceuticals makes up approximately 2.2% of Avidity Partners Management LP’s […]

Related Keywords

United States ,Neenam Patil ,Stifel Nicolaus ,Piper Sandler ,Holdings Channel ,Jazz Pharmaceuticals ,News Ratings For Jazz Pharmaceuticals Daily ,Jpmorgan Chase Co ,International Assets Investment Management ,Polaris Capital Management ,Nasdaq ,Dynamic Technology Lab Private Ltd ,Barclays ,Quarter For Jazz Pharmaceuticals ,Baupost Group ,Jazz Pharmaceuticals Stock ,Desjardins Global Asset Management Inc ,Avidity Partners Management ,Free Report ,Partners Management ,Capital Management ,Technology Lab Private Ltd ,Assets Investment Management ,Desjardins Global Asset Management ,Get Free Report ,Visit Holdingschannel ,Jazz Pharmaceuticals Daily ,